Eli Lilly and Company is a
prestigious company university
established in 1876 in United States. It is represented
by 238 scientists in the AD Scientific Index. The
university’s scientists are particularly concentrated in
Natural Sciences (62 scientists), Medical and Health Sciences (54 scientists), and Engineering & Technology (13 scientists).
* Total H Index Rankings
Ranking Based
On Selection: 1
psychosis
neurodegeneration
bioinformatics
genomics
drug development
H-Index Metrics
Total
Last 6 Years
Last 6 Years / Total
124
60
0.484
* Total H Index Rankings
Ranking Based
On Selection: 2
PBPK Models
DDI
CYPs
H-Index Metrics
Total
Last 6 Years
Last 6 Years / Total
78
35
0.449
* Total H Index Rankings
Ranking Based
On Selection: 3
Neuroscience & Drug Discovery
H-Index Metrics
Total
Last 6 Years
Last 6 Years / Total
76
35
0.461
* Total H Index Rankings
Ranking Based
On Selection: 4
GI cancer
translational research
lung cancer
phase 1 trials
H-Index Metrics
Total
Last 6 Years
Last 6 Years / Total
74
38
0.514
* Total H Index Rankings
Ranking Based
On Selection: 5
Drug Discovery
Informatics
Computational Chemistry
Biophysics
Nanotechnology
H-Index Metrics
Total
Last 6 Years
Last 6 Years / Total
67
54
0.806
* Total H Index Rankings
Ranking Based
On Selection: 6
H-Index Metrics
Total
Last 6 Years
Last 6 Years / Total
64
38
0.594
* Total H Index Rankings
Ranking Based
On Selection: 7
Neurodegeneration
Neuroscience
H-Index Metrics
Total
Last 6 Years
Last 6 Years / Total
62
31
0.500
* Total H Index Rankings
Ranking Based
On Selection: 8
Alzheimer's disease
Neurodegeneration
Drug discovery
H-Index Metrics
Total
Last 6 Years
Last 6 Years / Total
60
36
0.600
* Total H Index Rankings
Ranking Based
On Selection: 9
Osteoporosis
Migraine
Cardiovascular Disease
Drug Development
H-Index Metrics
Total
Last 6 Years
Last 6 Years / Total
55
34
0.618
* Total H Index Rankings
Ranking Based
On Selection: 10
oncology/I-O/autoimmune diseases
drug discovery
kinases
epigenetics
RNA modulation
H-Index Metrics
Total
Last 6 Years
Last 6 Years / Total
54
25
0.463
* Total H Index Rankings
Ranking Based
On Selection: 11
Diabetes
endocrinology
fatty liver disease
H-Index Metrics
Total
Last 6 Years
Last 6 Years / Total
52
22
0.423
* Total H Index Rankings
Ranking Based
On Selection: 12
Drug Discovery
G-proteins
GPCRs
Receptors
Pharmacology
H-Index Metrics
Total
Last 6 Years
Last 6 Years / Total
50
27
0.540
* Total H Index Rankings
Ranking Based
On Selection: 13
H-Index Metrics
Total
Last 6 Years
Last 6 Years / Total
49
19
0.388
* Total H Index Rankings
Ranking Based
On Selection: 14
Immuno-Oncology
H-Index Metrics
Total
Last 6 Years
Last 6 Years / Total
48
32
0.667
* Total H Index Rankings
Ranking Based
On Selection: 15
process chemistry
organic chemistry. pharmaceutical
green chemistry
catalysis
H-Index Metrics
Total
Last 6 Years
Last 6 Years / Total
47
29
0.617
* Total H Index Rankings
Ranking Based
On Selection: 16
Heart disease
inflammation
diabetes
noncoding RNAs
systems biology
H-Index Metrics
Total
Last 6 Years
Last 6 Years / Total
44
31
0.705
* Total H Index Rankings
Ranking Based
On Selection: 17
Drug Discovery and Development
Precision Medicine
Digital Health
Genetics
Orphan diseases
H-Index Metrics
Total
Last 6 Years
Last 6 Years / Total
44
27
0.614
* Total H Index Rankings
Ranking Based
On Selection: 18
Lipoprotein Metabolism and Atherosclerosis
H-Index Metrics
Total
Last 6 Years
Last 6 Years / Total
44
26
0.591
* Total H Index Rankings
Ranking Based
On Selection: 19
Cancer
H-Index Metrics
Total
Last 6 Years
Last 6 Years / Total
43
22
0.512
* Total H Index Rankings
Ranking Based
On Selection: 20
Alzheimer's disease
H-Index Metrics
Total
Last 6 Years
Last 6 Years / Total
42
36
0.857
* Total H Index Rankings
Ranking Based
On Selection: 21
H-Index Metrics
Total
Last 6 Years
Last 6 Years / Total
42
28
0.667
* Total H Index Rankings
Ranking Based
On Selection: 22
psychopharmamcology
H-Index Metrics
Total
Last 6 Years
Last 6 Years / Total
42
21
0.500
* Total H Index Rankings
Ranking Based
On Selection: 23
diabetes
cardiovascular diseases
osteoporosis
H-Index Metrics
Total
Last 6 Years
Last 6 Years / Total
41
24
0.585
* Total H Index Rankings
Ranking Based
On Selection: 24
Clinical research
patients
methodology
effectiveness
cost-effectiveness
H-Index Metrics
Total
Last 6 Years
Last 6 Years / Total
41
20
0.488
* Total H Index Rankings
Ranking Based
On Selection: 25
RNA
Oligonucleotides
Delivery of Novel Modalities
Virology
SARS-CoV-2
H-Index Metrics
Total
Last 6 Years
Last 6 Years / Total
40
33
0.825
David A Collier
Eli Lilly and Company
Indianapolis, United States
H-Index Metrics
Total
Last 6 Years
Last 6 Years / Total
124
60
0.484
psychosis
neurodegeneration
bioinformatics
genomics
drug development
Stephen Hall
Eli Lilly and Company
Indianapolis, United States
H-Index Metrics
Total
Last 6 Years
Last 6 Years / Total
78
35
0.449
Christian C Felder
Eli Lilly and Company
Indianapolis, United States
H-Index Metrics
Total
Last 6 Years
Last 6 Years / Total
76
35
0.461
Neuroscience & Drug Discovery
David R Ferry
Eli Lilly and Company
Indianapolis, United States
H-Index Metrics
Total
Last 6 Years
Last 6 Years / Total
74
38
0.514
Jiye Shi
Eli Lilly and Company
Indianapolis, United States
H-Index Metrics
Total
Last 6 Years
Last 6 Years / Total
67
54
0.806
Drug Discovery
Informatics
Computational Chemistry
Biophysics
Nanotechnology
Eswar Krishnan
Eli Lilly and Company
Indianapolis, United States
H-Index Metrics
Total
Last 6 Years
Last 6 Years / Total
64
38
0.594
Michael O'Neill
Eli Lilly and Company
Indianapolis, United States
H-Index Metrics
Total
Last 6 Years
Last 6 Years / Total
62
31
0.500
Martin Citron
Eli Lilly and Company
Indianapolis, United States
H-Index Metrics
Total
Last 6 Years
Last 6 Years / Total
60
36
0.600
JH Krege
Eli Lilly and Company
Indianapolis, United States
H-Index Metrics
Total
Last 6 Years
Last 6 Years / Total
55
34
0.618
Bob Campbell
Eli Lilly and Company
Indianapolis, United States
H-Index Metrics
Total
Last 6 Years
Last 6 Years / Total
54
25
0.463
oncology/I-O/autoimmune diseases
drug discovery
kinases
epigenetics
RNA modulation
Mark L Hartman
Eli Lilly and Company
Indianapolis, United States
H-Index Metrics
Total
Last 6 Years
Last 6 Years / Total
52
22
0.423
Diabetes
endocrinology
fatty liver disease
Francis Willard
Eli Lilly and Company
Indianapolis, United States
H-Index Metrics
Total
Last 6 Years
Last 6 Years / Total
50
27
0.540
Drug Discovery
G-proteins
GPCRs
Receptors
Pharmacology
Jonathan A Lee
Eli Lilly and Company
Indianapolis, United States
H-Index Metrics
Total
Last 6 Years
Last 6 Years / Total
49
19
0.388
Prachi Sharma
Eli Lilly and Company
Indianapolis, United States
H-Index Metrics
Total
Last 6 Years
Last 6 Years / Total
48
32
0.667
Tony Zhang
Eli Lilly and Company
Indianapolis, United States
H-Index Metrics
Total
Last 6 Years
Last 6 Years / Total
47
29
0.617
process chemistry
organic chemistry. pharmaceutical
green chemistry
catalysis
Scot J Matkovich
Eli Lilly and Company
Indianapolis, United States
H-Index Metrics
Total
Last 6 Years
Last 6 Years / Total
44
31
0.705
Heart disease
inflammation
diabetes
noncoding RNAs
systems biology
Sreekumar Pillai
Eli Lilly and Company
Indianapolis, United States
H-Index Metrics
Total
Last 6 Years
Last 6 Years / Total
44
27
0.614
Drug Discovery and Development
Precision Medicine
Digital Health
Genetics
Orphan diseases
Giacomo Ruotolo
Eli Lilly and Company
Indianapolis, United States
H-Index Metrics
Total
Last 6 Years
Last 6 Years / Total
44
26
0.591
Louis F Stancato
Eli Lilly and Company
Indianapolis, United States
H-Index Metrics
Total
Last 6 Years
Last 6 Years / Total
43
22
0.512
Stéphane Epelbaum
Eli Lilly and Company
Indianapolis, United States
H-Index Metrics
Total
Last 6 Years
Last 6 Years / Total
42
36
0.857
David H Adams
Eli Lilly and Company
Indianapolis, United States
H-Index Metrics
Total
Last 6 Years
Last 6 Years / Total
42
28
0.667
Joel Raskin
Eli Lilly and Company
Indianapolis, United States
H-Index Metrics
Total
Last 6 Years
Last 6 Years / Total
42
21
0.500
Imre Pavo
Eli Lilly and Company
Indianapolis, United States
H-Index Metrics
Total
Last 6 Years
Last 6 Years / Total
41
24
0.585
José Antonio Sacristán
Eli Lilly and Company
Indianapolis, United States
H-Index Metrics
Total
Last 6 Years
Last 6 Years / Total
41
20
0.488
Clinical research
patients
methodology
effectiveness
cost-effectiveness
Andrew C Adams
Eli Lilly and Company
Indianapolis, United States
H-Index Metrics
Total
Last 6 Years
Last 6 Years / Total
40
33
0.825
RNA
Oligonucleotides
Delivery of Novel Modalities
Virology
SARS-CoV-2